| Literature DB >> 32712937 |
Raheleh Kujlu1, Mostafa Mahdavianpour2, Farshid Ghanbari2.
Abstract
Natural organic matter reacted with chlorine used for disinfection, and finally, trihalomethanes (THMs) are formatted. The main purpose of this study was to determine four THM concentrations and human health cancer risk and non-cancer risk assessment from exposure through oral ingestion, dermal contact, and inhalation for males and females in Abadan. Two sampling sites were selected, and five samples before and after treatment by two different water treatment systems (RO and ion exchange) were collected every week. Results showed that total THM concentrations before and after treatment by RO were 98.1 and 8.88 μg/L, and ion exchange ranged between 101.9 and 14.96 μg/L, respectively, that before treatment was upper than the maximum of 80 mg/L recommended by USEPA. Inhalation was the primary route of exposure by around 80-90% of cancer risk. Total cancer risk was higher than the USEPA acceptable limit of 10-6 via three exposure routes. Oral route has the higher hazard index values than dermal ways.Entities:
Keywords: Abadan; Disinfection by-products; Drinking water; Risk assessment; Trihalomethanes
Mesh:
Substances:
Year: 2020 PMID: 32712937 PMCID: PMC7603476 DOI: 10.1007/s11356-020-09990-9
Source DB: PubMed Journal: Environ Sci Pollut Res Int ISSN: 0944-1344 Impact factor: 4.223
Fig. 1The location of sampling sites in the present study
Parameter definition and their values which were used in this study
| Type of parameter | Parameter | Symbol | Unit | Value | References |
|---|---|---|---|---|---|
| General | THMs concentration | μg/L | Table | This study | |
| Average lifetime | AT | Days | Male 64 years and female 66 years | Siddique et al. ( | |
| Body weight | BW | kg | 65 kg (67.2 kg, female 63.9 kg) | Siddique et al. ( | |
| Exposure duration | ED | Year | Male 64 years and female 66 years | Siddique et al. ( | |
| Exposure frequency | EF | Days/year | 365 | Abbas et al. ( | |
| Oral ingestion | Ingestion rate | IR | L/day | 2 | USEPA ( |
| Dermal | Area of surface skin expose to water | SA | m2 | Male: 1.7 Female: 1.53 | Wang et al. ( |
| Chemical specific dermal permeability constant in water measured at 25 °C | cm/h | Chloroform: 0.16 BDCM: 0.18 DBCM: 0.2 Bromoform: 0.21 | Wang et al. ( | ||
| Exposure time considered during showering and bathing activities | h | 0.25 | Legay et al. ( | ||
| Inhalation absorption | THM concentration in air | Ca | μg/L | Equation | Little ( |
| Air intake rate | m3/h | 0.83 | Wang et al. ( | ||
| Carcinogenic slope factor (Ingestion/dermal) | CSF | mg/kg/day | Chloroform: 0.0061 BDCM: 0.062 DBCM: 0.084 Bromoform: 0.0079 | Lee et al. ( | |
| Carcinogenic slope factor (inhalation) | CSF | mg/kg/day | Chloroform: 0. 081 BDCM: 0.13 DBCM: 0.094 Bromoform: 0.0039 | Lee et al. ( | |
| Hazard index | Reference dose | RfD | mg/kg/day | Chloroform 0.01 (BDCM), 0.02 (DBCM), 0.02 (bromoform) 0.02 | Abbas et al. ( |
Parameter values used in the modeling
| Parameter | THMs | value | Reference |
|---|---|---|---|
| KOLA (L/min) | Chloroform BDCM DBCM Bromoform | 7.4 5.9 4.6 3.7 | Genisoglu et al. ( |
| QL (L/min) | 5 | Little ( | |
| Vs (m3) | 6 | Genisoglu et al. ( | |
| Qg (L/min) | 50 | Little ( | |
| H at 40 °C | Chloroform BDCM DBCM Bromoform | 0.350 0.186 0.102 0.058 | |
| Kp (cm/h) | Chloroform BDCM DBCM Bromoform | 0.16 0.18 0.20 0.21 | Legay et al. ( |
| IRa (m3/h) | inhalation | 20 |
Summary of THMs level (µg/L) before and after treatment by RO and ion exchange
| Locality | Chloroform | BDCM | DBCM | Bromoform | Total THMs | Removal% | |
|---|---|---|---|---|---|---|---|
| School, before T | 5 | 5.6 | 18.26 | 37.6 | 36.64 | 98.1 | |
| Dormitory, before T | 5 | 21.2 | 25.2 | 34.4 | 21 | 101.8 | |
| school, after T | 5 | 0.84 | 2.2 | 3.4 | 2.44 | 8.88 | 90.9% |
| Dormitory, after T | 5 | 1.82 | 3.9 | 6.2 | 3.04 | 14.96 | 85.3% |
General water quality parameters for different samples
| Parameter | School, before T | School, after T | Removal% | Dormitory, before T | Dormitory, after T | Removal% |
|---|---|---|---|---|---|---|
| pH | 7.22 | 7.16 | 7.04 | 7 | ||
| TOC | 1.3 | 0.142 | 89% | 0.82 | 0.108 | 86.8% |
| Br | 0.38 | 0.03 | 0.38 | 0.058 | ||
| Cl2 | 0.3 | 0 | 0.76 | 0 |
Fig. 2Cancer risk assessment of THMs via oral (after treatment with ion exchange), dermal, and inhalation (before treatment with ion exchange) for both sexes in the dormitory
Fig. 3Cancer risk assessment of THMs via oral (after treatment with ion exchange), dermal, and inhalation (before treatment by ion exchange) for males and females in school
Mean health risk of THMs through three exposure routes (ingestion, dermal contact, and inhalation) and the contribution of THM species
| System | THMs | Oral | Dermal | Inhalation |
|---|---|---|---|---|
| Ion exchange (male) | Chloroform | 3.03831E-07 2% | 1.20331E-07 2% | 0.000154246 87% |
| BDCM | 6.61741E-06 30% | 1.63552E-06 31% | 1.18211E-05 6% | |
| DBCM | 1.42529E-05 65% | 3.36092E-06 63% | 8.36157E-06 5% | |
| Bromoform | 6.57252E-07 3% | 2.02608E-07 4% | 3.19726E-06 2% | |
| TTHMs | 2.18E-05 11% | 5.32E-06 2% | 0.000178 87% | |
| Cancer risk | Acceptable low risk | Acceptable low risk | Unacceptable risk | |
| Ion exchange (female) | Chloroform | 3.12869E-07 2% | 2.92508E-08 1% | 0.000158834 87% |
| BDCM | 6.81424E-06 30% | 3.1148E-06 48% | 1.21728E-05 6% | |
| DBCM | 1.46768E-05 65% | 3.1148E-06 48% | 8.61029E-06 5% | |
| Bromoform | 6.76802E-07 3% | 1.87771E-07 3% | 3.29236E-06 2% | |
| TTHMs | 2.25E-05 11% | 6.45E-06 3% | 0.000183 86% | |
| Cancer risk | Acceptable low risk | Acceptable low risk | Unacceptable risk | |
| RO (male) | Chloroform | 1.4023E-07 1% | 3.17854E-08 1% | 4.07443E-05 64% |
| BDCM | 3.7329E-06 31% | 1.1851E-06 22% | 8.56563E-06 13% | |
| DBCM | 7.81609E-06 64% | 3.67356E-06 70% | 9.13939E-06 14% | |
| Bromoform | 5.27531E-07 4% | 3.53502E-07 7% | 5.57846E-06 9% | |
| TTHMs cancer risk | 1.22E-05 15% | 5.24E-06 6% | 6.40E-05 79% | |
| Cancer risk | Acceptable low risk | Acceptable low risk | Acceptable high risk | |
| RO (female) | Chloroform | 1.44401E-07 1% | 2.94578E-08 1% | 4.19562E-05 64% |
| BDCM | 3.84393E-06 31% | 1.09832E-06 22% | 8.82042E-06 13% | |
| DBCM | 8.04858E-06 64% | 3.40455E-06 70% | 9.41124E-06 14% | |
| Bromoform | 5.43223E-07 4% | 3.27615E-07 7% | 5.74438E-06 9% | |
| TTHMs cancer risk | 1.26E-05 15% acceptable low risk | 4.86E-06 6% acceptable low risk | 6.59E-05 79% acceptable high risk |
Fig. 4Hazard index of THMs through ingestion and dermal contact for males in dormitory and school
Fig. 5Hazard index of THMs through ingestion and dermal contact for females in dormitory and school